![]() | ![]() |
Formats:
|
||||||||||||||||
Copyright © 2006, European Molecular Biology Organization Timely anaphase onset requires a novel spindle and kinetochore complex comprising Ska1 and Ska2 1Department of Cell Biology, Max–Planck–Institute for Biochemistry, Martinsried, Germany 2These authors contributed equally to this work aDepartment of Cell Biology, Max-Planck Institute for Biochemistry, Am Klopferspitz 18, 82152 Martinsried, Germany. Tel.: +49 89 8578 3100/3110; Fax: +49 89 8578 3102; E-mail: nigg/at/biochem.mpg.de *These authors contributed equally to this work Received August 4, 2006; Accepted October 12, 2006. This article has been cited by other articles in PMC.Abstract Chromosome segregation during mitosis requires chromosomes to undergo bipolar attachment on spindle microtubules (MTs) and subsequent silencing of the spindle checkpoint. Here, we describe the identification and characterisation of a novel spindle and kinetochore (KT)-associated complex that is required for timely anaphase onset. The complex comprises at least two proteins, termed Ska1 (Spindle and KT Associated 1) and Ska2. Ska1 associates with KTs following MT attachment during prometaphase. Ska1 and Ska2 interact with each other and Ska1 is required for Ska2 stability in vivo. Depletion of either Ska1 or Ska2 by small interfering RNA results in the loss of both proteins from the KT. The absence of Ska proteins does not disrupt overall KT structure, but KT fibres show an increased cold-sensitivity. Most strikingly, Ska-depleted cells undergo a prolonged checkpoint-dependent delay in a metaphase-like state. This delay is characterised by the recruitment of Mad2 protein to a few KTs and the occasional loss of individual chromosomes from the metaphase plate. These data suggest that the Ska1/2 complex plays a critical role in the maintenance of the metaphase plate and/or spindle checkpoint silencing. Keywords: kinetochore, Mad2, metaphase, microtubules, spindle checkpoint Introduction Upon entry into mitosis, the microtubule (MT) network is rearranged to form the mitotic spindle, which then brings about the segregation of sister chromatids. Central to this process is the proper attachment of spindle MTs to kinetochores (KTs), proteinaceous structures assembled on centromeric chromatin (Cleveland et al, 2003; Maiato et al, 2004). KT–MT interactions are important for both chromosome congression during prometaphase and subsequent chromosome segregation during anaphase. In addition, they regulate the activity of the spindle assembly checkpoint, a surveillance mechanism that monitors full MT attachment to KTs and/or the tension that develops in-between sister chromatids in response to bipolar attachment (Musacchio and Hardwick, 2002; Cleveland et al, 2003). The spindle checkpoint is silenced only after all KTs have undergone bipolar attachment and thus contributes to ensure the synchronous and error-free segregation of chromosomes. As revealed by electron tomography, mammalian KTs display a trilaminar structure, comprising an inner KT plate directly adjacent to (and inclusive of) the centromeric heterochromatin and an outer plate with its associated corona (McEwen et al, 1998). In mammals, the outer KT plate provides about 20–30 end-on MT attachment sites (Rieder, 1982). Recent studies indicate that a multitude of proteins cooperate to bring about and regulate the highly dynamic KT–MT interactions that are required for chromosome movement during mitosis (Biggins and Walczak, 2003; Cleveland et al, 2003; McAinsh et al, 2003; Maiato et al, 2004; Rieder, 2005). Prominent among the proteins implicated in MT capture at KTs are the Hec1/Ndc80 complex (Ciferri et al, 2005; DeLuca et al, 2005; Emanuele et al, 2005), MT-dependent motors (Cleveland et al, 2003) and the MT plus end proteins (+TIPs) CLIP-170, CLASP and EB1 (Maiato et al, 2004). Moreover, several Ran-regulated proteins (e.g. RanGAP1, RanBP2, HURP) (Joseph et al, 2004; Sillje et al, 2006; Wong and Fang, 2006) have been implicated in the stabilisation of KT-associated MT bundles (KT-fibres). A single unattached KT is sufficient to prevent anaphase onset by maintaining the spindle checkpoint in an active state (Rieder et al, 1994). The exact functioning of the spindle checkpoint is not yet understood, but a number of evolutionarily conserved spindle checkpoint proteins have been characterised. One prevailing model holds that the spindle checkpoint proteins Mad2 and/or BubR1 sequester Cdc20, an activating factor of the E3 ubiquitin-ligase known as anaphase promoting complex/cyclosome (APC/C). Inhibition of the APC/C then prevents the polyubiquitylation and hence degradation of key mitotic regulatory proteins, including cyclin B and securin (Peters, 2002). Upon bipolar attachment of all KTs to MTs the spindle checkpoint is silenced, followed by chromosome segregation and exit from mitosis (Musacchio and Hardwick, 2002). To obtain further insight into the processes that regulate mitotic chromosome congression and segregation, we recently conducted a proteomic survey of the human mitotic spindle (Sauer et al, 2005). This resulted in the identification of 151 known spindle proteins, including centrosome and KT-associated proteins, as well as 154 previously uncharacterised components. Here, we have examined C18Orf24 (now termed Spindle and KT Associated 1 (Ska1)) and show that this novel protein indeed localises to both the mitotic spindle and KTs. Ska1 binds another novel spindle and KT-associated protein, FAM33A (now termed Ska2), with which it forms a KT-associated protein complex. Depletion of the Ska complex results in a prolonged mitotic delay even though most chromosomes are aligned in a near-perfect metaphase plate. The most straightforward interpretation of this unusual phenotype is that Ska-depleted cells are unable to maintain stable KT–MT interactions and concomitantly fail to satisfy the spindle assembly checkpoint. Results Identification of Ska1 at spindle MTs and outer KTs C18Orf24 was previously identified as a putative spindle component in a mass spectrometry-based spindle inventory (Sauer et al, 2005). Inspection of the primary sequence of this 30 kDa protein revealed no known structural motifs, except for a predicted N-terminal coiled-coil domain. To determine if C18Orf24 constitutes a genuine spindle component, we transiently expressed the myc-tagged protein in HeLa S3 cells and analysed its localisation by indirect immunofluorescence (IF) microscopy. Co-staining with α-tubulin showed that the myc-tagged protein partly co-localised with spindle MTs in mitotic cells (Figure 1A
To investigate the localisation of endogenous Ska1, a polyclonal rabbit antibody was raised. This antibody detected a prominent band of the expected size in Western blots performed on whole HeLa S3 cell lysates (Supplementary Figure 1). It also stained both spindle and KT structures in mitotic cells (Figure 1B Requirements for Ska1 localisation to KTs As Ska1 staining at KTs increased during prometaphase (Figure 1B
Taken together, the above data suggested that KT–MT interactions regulate the accumulation and maintenance of Ska1 at KTs. In analogy to other proteins whose KT association had previously been shown to depend on MTs (Joseph et al, 2004), it was tempting to conclude that MTs are required for transporting Ska1 to KTs. Surprisingly, however, cold-induced depolymerisation of MTs did not result in the loss of Ska1 from KTs (Figure 2B In contrast to Ska1, the KT localisation of the spindle checkpoint protein Mad2 is lost upon MT attachment (Waters et al, 1998), but can readily be restored by nocodazole treatment (Figure 2D To determine which proteins might be required for KT localisation of Ska1, several KT-associated proteins were depleted by small interfering RNA (siRNA). Of all the proteins tested, only depletion of the outer KT protein Hec1 clearly reduced the concentration of Ska1 at KTs (Figure 3A
Ska1 interacts with Ska2 (FAM33A) As the above experiments had failed to reveal any binding partners of Ska1, we performed a yeast two-hybrid screen with full-length Ska1 as bait. This screen did not yield known KT proteins, but resulted in the repeated isolation of cDNAs coding for a 14 kDa protein (Figure 4A
To confirm the interaction between Ska1 and Ska2, tagged versions of the two proteins were produced in vitro by coupled transcription–translation, in the presence of 35S-methionine and immunoprecipitations were performed. Myc-tagged Ska1 and Ska2 readily precipitated FLAG-Ska2 and FLAG-Ska1, respectively. In contrast, FLAG-tagged Polo-like kinase 1 (Plk1), used as a negative control, was not co-precipitated, attesting to the specificity of the observed interactions (Figure 4B An antibody raised against Ska2 recognised a single protein in interphase cells, but two forms in mitotically-arrested cells (Supplementary Figure 5A). Both bands were sensitive to siRNA-mediated depletion (Figure 4F The cell cycle expression of Ska1 and Ska2 was explored by Western blot analysis. Both proteins were present at similar levels in asynchronous, G1/S phase (aphidicolin-treated) and mitotic (nocodazole/taxol-treated) cells (Supplementary Figure 5A). To explore whether the slower migrating form of Ska2 present in mitotically arrested cells reflects phosphorylation, its sensitivity to phosphatase treatment was examined. No change in Ska2 migration could be observed in response to alkaline phosphatase, type 1 phosphatase or lambda phosphatase, although BubR1 and Cdc27, two mitotic phosphoproteins known to undergo phosphorylation-induced mobility changes (Li et al, 1999; Kraft et al, 2003), readily responded to these treatments (Supplementary Figure 5B; A Hanisch and HHW Silljé, unpublished data). Thus, Ska2 is either phosphorylated on a site that is particularly resistant to phosphatase or, alternatively, subjected to another type of modification. Whatever its molecular identity, the variant Ska2 persisted for more than 2 h after release of nocodazole-arrested cells, long after cyclin B was degraded (Supplementary Figure 5C). These results show that both Ska1 and Ska2 proteins are expressed at near constant levels throughout the cell cycle, but that an as yet unidentified variant of Ska2 is present throughout mitosis. Ska1 and Ska2 are required for proper mitotic progression To examine the functional consequence of depleting the Ska complex, HeLa S3 cells were depleted of Ska proteins and then examined by IF microscopy. First, we asked whether the absence of the Ska complex disrupts KT structure. None of the KT- and centromere-associated proteins analysed, including Bub1, BubR1, Mad1, Hec1, Aurora-B, CENP-E, CENP-F, RanBP2, RanGAP1, CLIP170 and EB1, was significantly affected in its localisation upon depletion of Ska proteins (A Hanisch and HHW Silljé, unpublished data), indicating that the Ska complex is not required for overall KT structure. However, when cells were examined 48 h after siRNA-mediated depletion of either Ska1 or Ska2, a strong increase in mitotic index could be observed (Figure 5A
Quantification of the above data showed that control (GL2)-depleted cells proceeded from prophase to anaphase onset in 47±9.7 min. In Ska1- and Ska2-depleted cells this period was highly variable, but on average took about four times longer (179±141 and 174±120 min, respectively). Most remarkably, most Ska1- and Ska2-depleted cells (57 and 67%, respectively), as well as all (GL2- treated) controls, completed alignment of chromosomes in a metaphase plate within 60 min after onset of chromosome condensation (Figure 5D Role of Ska complex in stabilisation of KT–MT interaction and checkpoint silencing To further characterise the molecular mechanism underlying the Ska depletion phenotype, Ska-depleted cells were challenged by short exposure to low temperature, a procedure known to test the stability of KT-fibres (Rieder, 1981). When compared to control cells and Nuf2-depleted cells – which are known to be impaired in KT–MT attachment (DeLuca et al, 2002) – the KT-fibres of Ska-depleted cells showed an intermediate cold-sensitivity (Figure 6A 2) (Figure 6BDiscussion In this study, we describe the characterisation of Ska1, a novel spindle and KT-associated protein originally identified as a candidate spindle component by mass spectrometry (Sauer et al, 2005). Furthermore, we identify a second novel protein, termed Ska2 that interacts with Ska1 both in vitro and in vivo. Complex formation between the two proteins is required for Ska2 stability as well as Ska protein localisation to spindle MTs and KTs. During prometaphase, the Ska complex associates with KTs only after MT attachment, suggesting that this complex is not required for KT–MT interactions per se. Depletion studies by siRNA showed that the absence of the Ska complex did not overtly affect general KT structure. Furthermore, although increased cold-sensitivity suggests a weakening of KT-fibres, initial chromosome congression was only modestly impaired. Instead, depletion of the Ska complex caused cells to spend prolonged periods of time in a metaphase-like state characterised by occasional loss of individual chromosomes and a persistent activation of the spindle checkpoint. Taken together, our data indicate that the Ska complex is required for the maintenance of chromosomes in a fully aligned metaphase plate and for checkpoint silencing. Requirements for KT localisation of Ska proteins At physiological temperature, Ska1 localisation to KTs required KT–MT attachments, but at low temperature the protein associated with KTs in the absence of MTs. Other proteins, including RanGAP1 and RanBP2, have previously been shown to localise to KTs in an MT-dependent manner and this is thought to reflect MT-dependent transport (Joseph et al, 2004). However, the fact that Ska1 showed a strong concentration at KTs of cold-treated cells, even though MTs were absent, argues that Ska1 does not depend on MTs for its transport to KTs. Instead, the data suggest that Ska1 binding to KTs depends on docking sites that, at physiological temperature, are created by MT attachment, but those can also be generated when cells are incubated in the cold, in the absence of MTs. One possibility is that docking sites are generated by a shift in the balance of opposing enzymatic activities (e.g., a disturbance of kinase/phosphatase equilibria). Alternatively, it is possible that Ska proteins turn over constitutively at KTs and that their release requires an energy-dependent enzymatic activity, which is blocked by MT attachment (at physiological temperature) or cold treatment. Regardless of the molecular nature of the Ska docking sites, it is striking that Ska proteins and Mad2 display opposite requirements for KT localisation under all conditions examined. At physiological temperature, Ska docking sites are generated in response to MTs attachment, whereas, concomitantly, Mad2 is lost from KTs. Conversely, nocodazole treatment abolishes Ska localisation to KTs but causes the recruitment of Mad2, and finally, cold treatment restores Ska docking sites even in the absence of MTs, while inducing the loss of Mad2. Considering the striking correlation between the creation of Ska binding sites and the loss of Mad2 from KTs, the question arises of whether the recruitment of the Ska complex directly contributes to the release of Mad2 from KTs. However, the observation that Mad2 was absent from the KTs of most aligned chromosomes in Ska-depleted cells argues against a direct, active role of the Ska complex in Mad2 displacement. Instead, a particular structural change produced at KTs upon MT attachment (or cold treatment in the absence of MTs) may cause both Ska recruitment and Mad2 displacement. Does the Ska complex functionally resemble the yeast Dash/Dam1 complex? As indicated by comparative sequence analyses, homologues of Ska1 are present in the genomes of vertebrates and invertebrates, as well as plants. Ska2 genes could be identified with confidence only in vertebrates, but considering the functional interaction between Ska1 and Ska2, we presume that Ska2 genes are also present in invertebrates and plants, although they are impossible to detect by current search algorithms. Neither Ska1 nor Ska2 homologues could be identified in yeast, but again, this does not necessarily imply that functional homologues are truly absent. In recent years, it has become increasingly apparent that yeast and vertebrate KTs share many more components than had previously been appreciated (Meraldi et al, 2006). One notable exception to this conclusion concerns the yeast Dash/Dam1 complex, comprising 10 different small subunits for which no counterpart has yet been identified in mammals (Cheeseman et al, 2001; Miranda et al, 2005; Westermann et al, 2005). It is intriguing, therefore, that several of the properties of the Ska complex described here are reminiscent of results described for the yeast Dash/Dam1 complex. Specifically, the Dash/Dam1 complex of Saccharomyces cerevisiae has been shown to localise to spindle MTs and KTs (Hofmann et al, 1998; Cheeseman et al, 2001) and to require both an intact Ndc80 complex (the yeast homologue of the human Hec1 complex) and MTs for KT localisation (Janke et al, 2002). Moreover, this budding yeast complex is known to contribute to the stabilisation of KT–MT interactions (Cheeseman et al, 2001; Miranda et al, 2005). Interestingly, the Dash/Dam1 complex is essential for viability in Saccharomyces cerevisiae (Hofmann et al, 1998) but not in Schizosaccharomyces pombe (Sanchez-Perez et al, 2005). Instead, mutations in Schizosaccharomyces pombe Dash/Dam1 proteins result in a delayed anaphase onset and persistent spindle checkpoint activation (Sanchez-Perez et al, 2005), similar to the Ska1 and Ska2 depletion phenotype described here. Thus, in spite of the absence of obvious sequence similarity between Ska1, Ska2 and any of the Dash/Dam1 complex components, it is possible that the human Ska complex and the yeast Dash/Dam1 complex perform at least partially similar roles. One interesting question for the future is whether Ska proteins are able to form ring structures around MTs, as described for the Dash/Dam1 complex (Miranda et al, 2005; Westermann et al, 2005). Ska complex is required for timely anaphase onset Depletion of human Ska proteins did not affect the localisation of any other KT protein examined so far, arguing that the Ska complex is not required for overall KT structure. Moreover, the mitotic spindle appeared to form normally in Ska-depleted cells and although KT-fibres were weakened, chromosome congression was not fundamentally impaired in a majority of cells. However, it would be premature to exclude that a complete (genetic) knockout of Ska1 and Ska2 might reveal a more severe phenotype. The most striking consequence of siRNA-mediated depletion of Ska proteins was a delayed anaphase onset preceded by a prolonged metaphase-like state. This unusual phenotype was characterised by individual chromosomes occasionally moving out of (and back into) the metaphase plate, rare KTs staining positive for Mad2 and persistent spindle checkpoint activation. On the basis of these results, we propose that the Ska complex is required for stabilising KT–MT attachments and/or checkpoint silencing. In principle, the failure of Ska-depleted cells to silence the spindle checkpoint could be a consequence of an occasional destabilisation of KT–MT interactions at individual chromosomes. Alternatively, Ska-depleted cells could primarily be impaired in switching off the checkpoint, in which case the occasional loss of individual chromosomes from the metaphase plate could be a consequence of the extended metaphase delay. In particular, it is tempting to speculate that the Ska complex could contribute to functionally down regulate some of the KT-associated proteins that are responsible for relaying the inhibitory checkpoint signal (e.g. one or several of the checkpoint kinases). Thus, we anticipate that the discovery of the vertebrate Ska complex will prompt new lines of enquiry into the coupling of MT attachment to the KT and checkpoint silencing. Materials and methods Cloning procedures For cloning of Ska1 (C18Orf24), a cDNA clone (IMAGp998H169724Q) was obtained from the ‘Deutsches Ressourcenzentrum für Genomforschung' (RZPD). This cDNA was cloned in-frame into a pcDNA3.1 vector (Invitrogen, Carlsbad, CA) encoding either an N-terminal 3xmyc tag or a FLAG tag. Ska2 (FAM33A) was cloned into the same vectors using a yeast two-hybrid clone as PCR template. Antibody production In order to produce Ska1- and Ska2-specific antibodies, the polyhistidine-tagged proteins were expressed in Escherichia coli from pET-28 vectors (EMD Biosciences, Madison, WI) and purified under denaturing conditions. New Zealand's white rabbits were used to produce antisera against these recombinant proteins (Charles River Laboratories, Romans, France). The sera were affinity purified using AminoLink Plus Immobilization Kit (Pierce Biotechnology, Rockford, IL) coated with the respective antigens according to the manufacturer's protocol. Cell culture and synchronisation HeLa S3 cells were grown at 37°C under 5% CO2 in DMEM (Invitrogen), supplemented with 10% FCS and penicillin–streptomycin (100 IU/ml and 100 μg/ml, respectively). Cell synchronisation and K-fibre stability assays were described previously (Sillje et al, 2006). Transient transfections and siRNA Plasmid transfections were performed using FUGENE6 reagent (Roche Diagnostics, Indianapolis, IN), according to the manufacturer's instructions. SiRNA duplexes were transfected using Oligofectamine (Invitrogen) as described elsewhere (Elbashir et al, 2001). The sequence of the siRNA duplex for targeting Ska1 was: 5′-CCC GCT TAA CCT ATA ATC AAA-3′ and for Ska2: 5′-AAG AAA TCA AGA CTA ATC ATC TT-3′ (Qiagen, Hilden, Germany). Similar results were obtained with two other siRNAs targeting different sequences in Ska1: 5′-CTG GAG ATT TGT GTC AAT AAT-3′ and Ska2: 5′-TTT CAC ATG CCA GAT TTA TGA-3′. Hec1, Mad2 and Nuf2 were depleted using established siRNAs targeting published sequences (DeLuca et al, 2002; Stucke et al, 2004). As a control, a duplex (GL2) targeting luciferase was used (Elbashir et al, 2001). IF microscopy Cells were grown on coverslips and fixed and permeabilised as described previously (Sillje et al, 2006). Primary antibodies used in this study were rabbit anti-Ska1 serum (1:5000), mouse mAb anti-myc (1:10, 9E10 tissue culture supernatant), mouse mAb anti-α-tubulin-FITC (1:1000, Santa-Cruz Biotechnology, Santa Cruz, CA), human CREST autoimmuneserum (1:5000, Immunovision, Springdale, AR), mouse mAb anti-Hec1 (1:1000, Abcam, Cambridge, UK), rabbit anti-Mad2 (1:1000, Bethyl, Montgomery, TX) and goat anti-RanGAP1 and anti-RanBP2 (1:1000, 1:500, respectively, gifts from Dr Frauke Melchior, University. of Göttingen, Germany). Primary antibodies were detected with Alexa-Fluor-488- and Alexa-Fluor-555-conjugated goat anti-mouse, anti-rabbit or anti-goat IgGs (1:1000, Molecular Probes, Eugene, OR), respectively. DNA was stained with DAPI (2 μg/ml). IF microscopy was performed using a Zeiss Axioplan II microscope (Zeiss, Jena, Germany) with Apochromat × 40 and × 63 oil immersion objectives, as described before (Sillje et al, 2006). For high-resolution images a Deltavision microscope (Applied Precision, Issaquah, WA) on an Olympus IX71 base, equipped with a PlanApo 60 × /1.40 oil immersion objective and a CoolSNAP HQ camera (Photometrics) was used for collecting 0.15 μm-distanced optical sections in the z-axis. Images at single focal planes (Figures 1C Live-cell imaging For live-cell imaging, an HeLa S3 cell line stably expressing histone H2B-GFP was used (Sillje et al, 2006). Cells were treated with siRNAs for 30 h, before changing the medium to CO2-independent medium and the culture dish was placed onto a heated sample stage within a heated chamber (37°C). Live-cell imaging was performed using the Plan Apo 40 × /0.95 objective on the above-described Deltavision microsope and Softworx software was used to collect and process data. Images were captured with 10% neutral density and 200 ms exposure times in 4 min intervals for 18 h with three stacks per field spaced 3 μm each. Yeast two-hybrid analysis A yeast two-hybrid screen was performed using a system described previously (James et al, 1996). Ska1 cDNA in the pFBT9 Gal4 DNA binding domain vector was used to screen a human HEK293 two-hybrid library (BD Clontech, Mountain View, CA). Clones able to activate both the Ade2 and His3 selection markers, specifically in the presence of the bait, were selected. In vitro coupled transcription translation The respective 3xmyc- and FLAG-tagged proteins were produced by in vitro coupled transcription translation (IVT) in the presence of 35S-methionine using the TNT T7 Quick Coupled Transcription/Translation System (Promega, Madison, WI). For immunoprecipitation these reactions were diluted in LS buffer (50 mM Tris pH 8.0, 100 mM NaCl, 0.1% NP40 and protease inhibitors) and incubated with anti-myc antibody (9E10) coated Protein G beads (Pierce Biotechnology, Rockford, IL) for 90 min at 4°C on a rotating wheel. After washing, samples were boiled in sample buffer and equal protein amounts of input and myc-precipitates were separated by SDS–PAGE and visualised by autoradiography. Cell extracts, immunoprecipitation and Western blot analysis Preparation of cell extracts and Western blot analysis were described previously (Hanisch et al, 2006). For immunoprecipation experiments Affi-Prep Protein A Support beads (Bio-Rad Laboratories, Hercules, CA) coated with either rabbit anti-Ska1, rabbit anti-Ska2 or rabbit IgGs as a control were used. For Western blot analysis, affinity purified rabbit anti-Ska1 (2.5 μg/ml), affinity purified rabbit anti-Ska2 (5 μg/ml), mAb anti-α-tubulin (1:1000, Sigma), mAb anti-Hec1 (1:1000, Abcam, Cambridge, UK), goat anti-RanGAP1, goat anti-RanBP2 (1:750, 1:6000, respectively, gift from Frauke Melchior), mAb anti-CLIP-170 (1:100, gift from Dr Franck Perez, Institut Curie, Paris, France), mAb anti-EB1 (1:1000, BD Transduction Laboratories), mAb anti-Plk1 (1:10, PL2, tissue culture supernatant), mAb anti-Cdc27 (1:250, BD Transduction Laboratories), mAb anti-BubR1 (1:10, 68–3–9, tissue culture supernatant), mAb anti-Bub1 (undiluted, 61–22–2, tissue culture supernatant), mAb anti-Aurora B (1:500, BD Transduction Laboratories), mAb anti-Mps1 (undiluted, 3-472-1, tissue culture supernatant), rabbit anti-MCAK (1:100, Cytoskeleton, Denver, CO), mAb anti-CENP-F (1:1000, BD Transduction Laboratories), goat anti-CENP-E (1:200, Santa Cruz), mAb anti-CENP-A (1:1000, MBL, Naka-ku Nagoya, Japan) and mAb anti-Cyclin B (1:1000, Upstate) were used and detected by ECL Supersignal (Pierce Biotechnology, Rockford, IL). Phosphatase assay HeLa S3 cells were arrested with either 1.6 μg/ml aphidicolin (G1/S-phase) or with 150 ng/ml nocodazole (M-phase) for 14 h. The corresponding cell lysates were either treated with Alkaline Phosphatase (Roche) or left untreated (in the presence of phosphatase inhibitors) for 1 h at 30°C. The phosphatase reaction was stopped by addition of sample buffer followed by boiling. Equal protein amounts were loaded and separated by SDS–PAGE, followed by Western blot analysis. Supplementary Movie 1 Click here to view.(169K, mpg) Supplementary Movie 2 Click here to view.(448K, mpg) Supplementary Movie 3 Click here to view.(463K, mpg) Supplementary Figures and Legends Click here to view.(931K, pdf) Acknowledgments We thank A Wehner for technical assistance, K Hofmann for sequence analysis, F Melchior and F Perez for generously providing us with antibodies and all our colleagues in the department for helpful discussions. This study was supported by the Max Planck Society, the ‘Deutsche Forschungsgemeinschaft' (SFB646) and the ‘Fonds der Chemischen Industrie'. References
|
PubMed related articles
Your browsing activity is empty. Activity recording is turned off. |
|||||||||||||||
Cell. 2003 Feb 21; 112(4):407-21.
[Cell. 2003]J Cell Sci. 2004 Nov 1; 117(Pt 23):5461-77.
[J Cell Sci. 2004]Nat Rev Mol Cell Biol. 2002 Oct; 3(10):731-41.
[Nat Rev Mol Cell Biol. 2002]Chromosoma. 1998 Dec; 107(6-7):366-75.
[Chromosoma. 1998]Int Rev Cytol. 1982; 79():1-58.
[Int Rev Cytol. 1982]Curr Biol. 2003 May 27; 13(11):R449-60.
[Curr Biol. 2003]Cell. 2003 Feb 21; 112(4):407-21.
[Cell. 2003]Annu Rev Cell Dev Biol. 2003; 19():519-39.
[Annu Rev Cell Dev Biol. 2003]J Cell Biol. 1994 Dec; 127(5):1301-10.
[J Cell Biol. 1994]Mol Cell. 2002 May; 9(5):931-43.
[Mol Cell. 2002]Nat Rev Mol Cell Biol. 2002 Oct; 3(10):731-41.
[Nat Rev Mol Cell Biol. 2002]Mol Cell Proteomics. 2005 Jan; 4(1):35-43.
[Mol Cell Proteomics. 2005]Mol Cell Proteomics. 2005 Jan; 4(1):35-43.
[Mol Cell Proteomics. 2005]J Biol Chem. 2002 May 10; 277(19):17200-8.
[J Biol Chem. 2002]Curr Biol. 2004 Apr 6; 14(7):611-7.
[Curr Biol. 2004]J Cell Biol. 1998 Jun 1; 141(5):1181-91.
[J Cell Biol. 1998]J Biol Chem. 2005 Aug 12; 280(32):29088-95.
[J Biol Chem. 2005]Mol Biol Cell. 2005 Feb; 16(2):519-31.
[Mol Biol Cell. 2005]Cell Growth Differ. 1999 Nov; 10(11):769-75.
[Cell Growth Differ. 1999]EMBO J. 2003 Dec 15; 22(24):6598-609.
[EMBO J. 2003]Curr Biol. 2003 May 27; 13(11):R449-60.
[Curr Biol. 2003]Chromosoma. 1981; 84(1):145-58.
[Chromosoma. 1981]J Cell Biol. 2002 Nov 25; 159(4):549-55.
[J Cell Biol. 2002]Science. 2002 Sep 27; 297(5590):2267-70.
[Science. 2002]Mol Cell Proteomics. 2005 Jan; 4(1):35-43.
[Mol Cell Proteomics. 2005]Curr Biol. 2004 Apr 6; 14(7):611-7.
[Curr Biol. 2004]Genome Biol. 2006; 7(3):R23.
[Genome Biol. 2006]J Cell Biol. 2001 Dec 24; 155(7):1137-45.
[J Cell Biol. 2001]Nat Struct Mol Biol. 2005 Feb; 12(2):138-43.
[Nat Struct Mol Biol. 2005]Mol Cell. 2005 Jan 21; 17(2):277-90.
[Mol Cell. 2005]J Cell Biol. 1998 Nov 16; 143(4):1029-40.
[J Cell Biol. 1998]Curr Biol. 2006 Apr 18; 16(8):731-42.
[Curr Biol. 2006]Nature. 2001 May 24; 411(6836):494-8.
[Nature. 2001]J Cell Biol. 2002 Nov 25; 159(4):549-55.
[J Cell Biol. 2002]Chromosoma. 2004 Aug; 113(1):1-15.
[Chromosoma. 2004]Curr Biol. 2006 Apr 18; 16(8):731-42.
[Curr Biol. 2006]Curr Biol. 2006 Apr 18; 16(8):731-42.
[Curr Biol. 2006]Curr Biol. 2006 Apr 18; 16(8):731-42.
[Curr Biol. 2006]Genetics. 1996 Dec; 144(4):1425-36.
[Genetics. 1996]Mol Biol Cell. 2006 Jan; 17(1):448-59.
[Mol Biol Cell. 2006]